Diabetic kidney disease: world wide difference of prevalence and risk factors

Osama Gheith, Nashwa Farouk, Narayanan Nampoory, Medhat A Halim, Torki Al-Otaibi, Osama Gheith, Nashwa Farouk, Narayanan Nampoory, Medhat A Halim, Torki Al-Otaibi

Abstract

Diabetic kidney disease - which is defined by elevated urine albumin excretion or reduced glomerular filtration rate (GFR) or both - is a serious complication that occurs in 20% to 40% of all diabetics. In this review we try to highlight the prevalence of diabetic nephropathy which is not uncommon complication of diabetes all over the world. The prevalence of diabetes worldwide has extended epidemic magnitudes and is expected to affect more than 350 million people by the year 2035. There is marked racial/ethnic besides international difference in the epidemiology of diabetic kidney disease which could be explained by the differences in economic viability and governmental infrastructures. Approximately one-third of diabetic patients showed microalbuminuria after 15 years of disease duration and less than half develop real nephropathy. Diabetic kidney disease (DKD) is more frequent in African-Americans, Asian-Americans, and Native Americans. Progressive kidney disease is more frequent in Caucasians patients with type 1 than type 2 diabetes mellitus (DM), although its overall prevalence in the diabetic population is higher in patients with type 2 DM while this type of DM is more prevalent. Hyperglycemia is well known risk factor for in addition to other risk factors like male sex, obesity, hypertension, chronic inflammation, resistance to insulin, hypovitaminosis D, and dyslipidemia and some genetic loci and polymorphisms in specific genes. Management of its modifiable risk factors might help in reducing its incidence in the nearby future.

Keywords: Chronic kidney disease; Diabetic kidney disease; End-stage kidney disease; Glomerular filtration rate; Microalbuminuria; Type 2 diabetes.

References

    1. Rabkin R. Diabetic nephropathy. Clin Cornerstone. 2003;5:1–11.
    1. American Diabetes Association . Nephropathy in Diabetes. Diabetes Care. 2004;27:S79–83.
    1. de Boer IH, Rue TC, Hall YN, Heagerty PJ, Weiss NS, Himmelfarb J. Temporal trends in the prevalence of diabetic kidney disease inthe United States. JAMA. 2011;305:2532–9.
    1. Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T. Diabetic nephropathy in type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia. 1983;25:496–501.
    1. American Diabetes Association. Standards of medical care in diabetes--2014. Diabetes Care. 2014;37 Suppl 1:S14–80.
    1. Soman SS, Soman AS, Rao TKS. Diabetic nephropathy. . Updated April 2004. Accessed May 2004.
    1. de Boer IH. Kidney disease and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes Care. 2014;37:24–30.
    1. de Boer IH, Afkarian M, Rue TC, Cleary PA, Lachin JM, Molitch ME. et al. Renal outcomes in patients with type 1 diabetes and macroalbuminuria. J Am Soc Nephrol. 2014;25:2342–50.
    1. US Renal Data System. USRDS Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2004.
    1. Piccoli GB, Grassi G, Cabiddu G, Nazha M, Roggero S, Capizzi I. et al. Diabetic Kidney Disease: A Syndrome Rather Than a Single Disease. Rev Diabet Stud. 2015;12:87–109.
    1. Mogensen CE. Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas. Diabetologia. 1999;42:263–85.
    1. Vrhovac B, Jakšić B, Reiner Ž, Vucelić B. Interna Medicina. Zagreb: Republic of Croatia; 2008. pp. 1258–9.
    1. Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetesmellitus. Lancet. 1982;1:1430–2.
    1. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortalityin maturity-onset diabetes . N Engl J Med. 1984;310:356–60.
    1. Orchard TJ, Dorman JS, Maser RE, Becker DJ, Drash AL Drash AL , Ellis D. et al. Prevalence of complications in IDDM by sex and durationPittsburgh Epidemiology of Diabetes Complications Study II . Diabetes. 1990;39:1116–1124.
    1. Chaturvedi N, Bandinelli S, Mangili R, Penno G, Rottiers RE, Fuller JH. Microalbuminuria in type 1 diabetes: rates, risk factors and glycemic threshold. Kidney Int. 2001;60:219–227.
    1. Hovind P, Tarnow L, Rossing P, Jensen BR, Graae M, Torp I. et al. Predictors of the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study. Brit Med J. 2004;328:1105–8.
    1. DCCT/EDIC research group. Effect of intensive diabetes treatment on albuminuria in type 1 diabetes: long-term follow-up of the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications study. Lancet Diabetes Endocrinol. 2014;2:793–800.
    1. Krolewski AS, Warram JH, Christlieb AR, Busick EJ, Kahn CR. The changing natural history of nephropathy in type I diabetes. Am J Med. 1985;78:785–94.
    1. Fioretto P, Steffes MW, Sutherland DE, Goetz FC, Mauer M. Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med. 1998;339(2):69–75.
    1. Retnakaran R, Cull CA, Thorne KI, Adler AI, Holman RR. Risk factors for renal dysfunction in type 2 diabetes: UK Prospective diabetes study 74. Diabetes. 2006;55:1832–9.
    1. Pavkov ME, Knowler WC, Bennett PH, Looker HC, Krakoff J, Nelson RG. Increasing incidence of proteinuria and declining incidence of end-stage renal disease in diabetic Pima Indians. Kidney Int. 2006;70:1840–6.
    1. Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64) Kidney Int. 2003;63:225–32.
    1. Young BA, Maynard C, Boyko EJ. Racial differences in diabetic nephropathy, cardiovascular disease, and mortality in a national population of veterans . Diabetes Care. 2003;26(8):2392–9.
    1. Cowie CC, Port FK, Wolfe RA, Savage PJ, Moll PP, Hawthorne VM. Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes . N Engl J Med. 1989;321:1074–9.
    1. Craig KJ, Donovan K, Munnery M, Owens DR, Williams JD, Phillips AO. Identification and management of diabetic nephropathy in the diabetes clinic. Diabetes Care. 2003;26:1806–11.
    1. Caramori ML, Kim Y, Huang C, Fish AJ, Rich SS, Miller ME. et al. Cellular basis of diabetic nephropathy 1 Study design and renal structural-functional relationships in patients with long-standing type 1 diabetes. Diabetes. 2002;51:506–13.
    1. United States Renal Data System: Incidence of reported end-stage renal disease. . Accessed March 10, 2009.
    1. American Diabetes Association: Total prevalence of Diabetes and Prediabetes. . Accessed March 10, 2009.
    1. Pavkov ME, Bennett PH, Knowler WC, Krakoff J, Sievers ML, Nelson RG. Effect of youth-onset type 2 diabetes mellitus on incidence of end-stage renal disease and mortality in young and middle-aged Pima Indians. JAMA. 2006;296:421–6.
    1. Bhalla V, Zhao B, Azar KM, Wang EJ, Choi S, Wong EC. et al. Racial/ethnic differences in the prevalence of proteinuric and nonproteinuric diabetic kidney disease. Diabetes Care. 2013;36:1215–21.
    1. Parving HH, Lewis JB, Ravid M, Remuzzi G, Hunsicker LG; DEMAND investigators. Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective. Kidney Int. 2006;69:2057–63.
    1. Unnikrishnan RI, Rema M, Pradeepa R, Deepa M, Shanthirani CS, Deepa R. et al. Prevalence and risk factors of diabetic nephropathy in an urban South Indian population: the Chennai Urban Rural Epidemiology Study (CURES 45) Diabetes Care. 2007;30:2019–24.
    1. Yokoyama H, Sone H, Oishi M, Kawai K, Fukumoto Y, Kobayashi M. Japan Diabetes Clinical Data Management Study Group Prevalence of albuminuria and renal insufficiency and associated clinical factors in type 2 diabetes: the Japan Diabetes Clinical Data Management study (JDDM15) Nephrol Dial Transplant. 2009;24:1212–9.
    1. Young BA, Katon WJ, Von Korff M, Simon GE, Lin EH, Ciechanowski PS. et al. Racial and ethnic differences in microalbuminuria prevalence in a diabetes population: the pathways study. J Am Soc Nephrol. 2005;16:219–28.
    1. Kaur P, Radhakrishnan E, Rao SR, Sankarasubbaiyan S, Rao TV, Gupte MD. The metabolic syndrome and associated risk factors in an urban industrial male population in South India. J Assoc Physicians India. 2010;58:363–71.
    1. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414:782–7.
    1. Ramachandran A, Ma RC, Snehalatha C. Diabetes in Asia. Lancet. 2010;375:408–18.
    1. Yoon KH, Lee JH, Kim JW, Cho JH, Choi YH, Ko SH. et al. Epidemic obesity and type 2 diabetes in Asia. Lancet. 2006;368:1681–8.
    1. Sridhar GR, Putcha V, Lakshmi G. Time trends in the prevalence of diabetes mellitus: Ten year analysis from southern India (1994-2004) on 19,072 subjects with diabetes. J Assoc Physicians India. 2010;58:290–4.
    1. Mohan V, Sandeep S, Deepa R, Shah B, Varghese C. Epidemiology of type 2 diabetes: Indian scenario. Indian J Med Res. 2007;125:217–30.
    1. Ravikumar P, Bhansali A, Walia R, Shanmugasundar G , Ravikiran M. Alterations in HbA(1c) with advancing age in subjects with normal glucose tolerance: Chandigarh Urban Diabetes Study Group . Diabet Med. 2011;28:590–4.
    1. Deepa M, Pradeepa R, Rema M, Mohan A, Deepa R, Shanthirani S. et al. The Chennai Urban Rural Epidemiology Study (CURES)--study design and methodology (urban component) (CURES-I) J Assoc Physicians India. 2003;51:863–70.
    1. Abdul FB. Type 2 diabetes and rural India. Lancet. 2007;369:273–4.
    1. Gupta SK, Singh Z, Purty AJ, Kar M, Vedapriya D, Mahajan P. et al. Diabetes prevalence and its risk factors in rural area of Tamil Nadu. Indian J Community Med. 2010;35:396–9.
    1. Jonas JB, Panda-Jonas S, Nangia V, Joshi PP, Matin A. Diabetes mellitus in rural India. Epidemiology. 2010;21:754–5.
    1. Pradeepa R, Anjana RM, Unnikrishnan R, Ganesan A, Mohan V, Rema M. Risk factors for microvascular complications of diabetes among South Indian subjects with type 2 diabetes--the Chennai Urban Rural Epidemiology Study (CURES) Eye Study-5. Diabetes Technol Ther. 2010;12:755–61.
    1. Agarwal SK, Srivastava RK. Chronic kidney disease in India: Challenges and solutions. Nephron Clin Pract. 2009;111:c197–203.
    1. Gray LJ, Tringham JR, Davies MJ, Webb DR, Jarvis J, Skinner TC. et al. Screening for type 2 diabetes in a multiethnic setting using known risk factors to identify those at high risk: A cross-sectional study. Vasc Health Risk Manag. 2010;6:837–42.
    1. Lightstone L, Rees AJ, Tomson C, Walls J, Winearls CG, Feehally J. et al. High incidence of end-stage renal disease in Indo-Asians in the UK. QJM. 1995;88:191–5.
    1. Barbour SJ, Er L, Djurdjev O, Karim M, Levin A. Differences in progression of CKD and mortality amongst Caucasian, Oriental Asian and South Asian CKD patients. Nephrol Dial Transplant. 2010;25:3663–72.
    1. Wilkinson E, Randhawa G, Farrington K, Greenwood R, Feehally J, Choi P, Lightstone L. Lack of awareness of kidney complications despite familiarity with diabetes: a multi-ethnic qualitative study. J Ren Care. 2011;37:2–11.
    1. Badran M, Laher I. Type II diabetes mellitus in Arabic-Speaking countries. Int J Endocrinol. 2012;2012:902873.
    1. Herman WH, Aubert RE, Engelgau MM, Thompson TJ, Ali MA, Sous ES. et al. Diabetes mellitus in Egypt: glycaemic control and microvascular and neuropathic complications. Diabet Med. 1998;15:1045–51.
    1. Jbour AS, Jarrah NS, Radaideh AM, Shegem NS, Bader IM, Batieha AM. et al. Prevalence and predictors of diabetic foot syndrome in type 2 diabetes mellitus in Jordan. Saudi Med J. 2003;24:761–4.
    1. Kadiki and Roaed RM. OA , Roaed RM . Epidemiological and clinical patterns of diabetes mellitus in Benghazi, Libyan Arab Jamahiriya. East Mediterr Health J. 1999;5:6–13.
    1. Centers for Disease Control and Prevention (CDC). National diabetes factsheet: national estimates and general information on diabetes and prediabetes in the United States, 2014. Atlanta, GA: Centers for Disease Control and Prevention; 2014.
    1. McDonald M, Hertz RP, Unger AN, Lustik MB. Prevalence, awareness, and management of hypertension, dyslipidemia, and diabetes among United States adults aged 65 and older. J Gerontol A Biol Sci Med Sci. 2009;64:256–63.
    1. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P. et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038–47.
    1. US Renal Data System. USRDS 2012 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2012.
    1. United States Renal Data System. USRDS 2008 annual data report. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2008.
    1. Sugarman JR, Reiber GE, Baumgardner G, Prela CM, Lowery J. Use of therapeutic footwear benefit among diabetic medicare beneficiaries in three states, 1995. Diabetes Care. 1998;21:777–81.
    1. American Diabetes Association. Economic costs of diabetes in the US in 2007. Diabetes Care. 2008;31:596–615.
    1. Brown AF, Mangione CM, Saliba D, Sarkisian CA . California Healthcare Foundation/American Geriatrics Society Panel on Improving Care for Elders with Diabetes . Guidelines for improving the care of older persons with diabetes mellitus. J Am Geriatr Soc. 2003;51(5 Suppl Guidelines):S265–80.
    1. Wenger NS, Shekelle PG, Roth CP. The ACOVE investigators: introduction to the assessing care of vulnerable elders-3 quality indicator measurement set. J Am Geriatr Soc. 2007;55(Suppl 2):S247–52.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir